0001209191-19-015645.txt : 20190304
0001209191-19-015645.hdr.sgml : 20190304
20190304163148
ACCESSION NUMBER: 0001209191-19-015645
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190301
FILED AS OF DATE: 20190304
DATE AS OF CHANGE: 20190304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tarriff Scott
CENTRAL INDEX KEY: 0001469124
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36306
FILM NUMBER: 19654208
MAIL ADDRESS:
STREET 1: 28 TUDOR ROSE TERRACE
CITY: MAHWAH
STATE: NJ
ZIP: 07430
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EAGLE PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000827871
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 TICE BOULEVARD, SUITE 315
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
BUSINESS PHONE: 201-326-5300
MAIL ADDRESS:
STREET 1: 50 TICE BOULEVARD, SUITE 315
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
FORMER COMPANY:
FORMER CONFORMED NAME: EAGLE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19880120
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-01
0
0000827871
EAGLE PHARMACEUTICALS, INC.
EGRX
0001469124
Tarriff Scott
C/O EAGLE PHARMACEUTICALS, INC.
50 TICE BLVD., SUITE 315
WOODCLIFF LAKE
NJ
07677
1
1
1
0
CEO
Common Stock
2019-03-01
4
S
0
12000
50.51
D
1537605
D
Common Stock
2019-03-01
4
S
0
12428
51.81
D
1525177
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.1615 to $51.0577 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.3201 to $52.2003 inclusive.
/s/ Scott Tarriff
2019-03-04